187 related articles for article (PubMed ID: 31922918)
1. Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
Frey MK; Kahn RM; Chapman-Davis E; Tubito F; Pires M; Christos P; Anderson S; Mukherjee S; Jordan B; Blank SV; Caputo TA; Sharaf RN; Offit K; Holcomb K; Lipkin S
J Clin Oncol; 2020 May; 38(13):1389-1397. PubMed ID: 31922918
[TBL] [Abstract][Full Text] [Related]
2. What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
Frey MK; Ahsan MD; Badiner N; Lin J; Narayan P; Nitecki R; Rauh-Hain JA; Moss H; Fowlkes RK; Thomas C; Bergeron H; Christos P; Levi SR; Blank SV; Holcomb K; Cantillo E; Sharaf RN; Lipkin S; Offit K; Chapman-Davis E
Cancer; 2022 Dec; 128(24):4241-4250. PubMed ID: 36305018
[TBL] [Abstract][Full Text] [Related]
3. Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?
Kahn RM; Ahsan MD; Chapman-Davis E; Holcomb K; Nitecki R; Rauh-Hain JA; Fowlkes RK; Tubito F; Pires M; Christos PJ; Tkachuk K; Krinsky H; Sharaf RN; Offit K; Lipkin S; Frey MK
Fam Cancer; 2023 Apr; 22(2):127-133. PubMed ID: 36207653
[TBL] [Abstract][Full Text] [Related]
4. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
Frey MK; Lee SS; Gerber D; Schwartz ZP; Martineau J; Lutz K; Reese E; Dalton E; Olsen A; Girdler J; Pothuri B; Boyd L; Curtin JP; Levine DA; Blank SV
Gynecol Oncol; 2020 Apr; 157(1):280-286. PubMed ID: 32057464
[TBL] [Abstract][Full Text] [Related]
5. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
6. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
8. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
Esteban I; Vilaró M; Adrover E; Angulo A; Carrasco E; Gadea N; Sánchez A; Ocaña T; Llort G; Jover R; Cubiella J; Servitja S; Herráiz M; Cid L; Martínez S; Oruezábal-Moreno MJ; Garau I; Khorrami S; Herreros-de-Tejada A; Morales R; Cano JM; Serrano R; López-Ceballos MH; González-Santiago S; Juan-Fita MJ; Alonso-Cerezo C; Casas A; Graña B; Teulé A; Alba E; Antón A; Guillén-Ponce C; Sánchez-Heras AB; Alés-Martínez JE; Brunet J; Balaguer F; Balmaña J
Psychooncology; 2018 Jun; 27(6):1530-1537. PubMed ID: 29498768
[TBL] [Abstract][Full Text] [Related]
9. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
Nilsson MP; Nilsson ED; Borg Å; Brandberg Y; Silfverberg B; Loman N
Breast Cancer Res Treat; 2019 Jan; 173(2):313-318. PubMed ID: 30311024
[TBL] [Abstract][Full Text] [Related]
10. Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.
Swisher EM; Rayes N; Bowen D; Peterson CB; Norquist BM; Coffin T; Gavin K; Polinsky D; Crase J; Bakkum-Gamez JN; Blank SV; Munsell MF; Nebgen D; Fleming GF; Olopade OI; Law S; Zhou A; Levine DA; D'Andrea A; Lu KH
JAMA Oncol; 2023 Nov; 9(11):1547-1555. PubMed ID: 37707822
[TBL] [Abstract][Full Text] [Related]
11. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
[TBL] [Abstract][Full Text] [Related]
12. The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees' outcome.
Platten U; Rantala J; Lindblom A; Brandberg Y; Lindgren G; Arver B
Fam Cancer; 2012 Sep; 11(3):371-9. PubMed ID: 22399327
[TBL] [Abstract][Full Text] [Related]
13. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Smit AK; Espinoza D; Newson AJ; Morton RL; Fenton G; Freeman L; Dunlop K; Butow PN; Law MH; Kimlin MG; Keogh LA; Dobbinson SJ; Kirk J; Kanetsky PA; Mann GJ; Cust AE
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):212-221. PubMed ID: 27702805
[TBL] [Abstract][Full Text] [Related]
15. The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial.
Brabyn S; Araya R; Barkham M; Bower P; Cooper C; Duarte A; Kessler D; Knowles S; Lovell K; Littlewood E; Mattock R; Palmer S; Pervin J; Richards D; Tallon D; White D; Walker S; Worthy G; Gilbody S
Health Technol Assess; 2016 Nov; 20(89):1-64. PubMed ID: 27922448
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.
Aspinwall LG; Taber JM; Leaf SL; Kohlmann W; Leachman SA
Psychooncology; 2013 Feb; 22(2):276-89. PubMed ID: 23382133
[TBL] [Abstract][Full Text] [Related]
17. Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.
DudokdeWit AC; Tibben A; Duivenvoorden HJ; Niermeijer MF; Passchier J; Trijsburg RW
Am J Med Genet; 1998 Jan; 75(1):62-74. PubMed ID: 9450860
[TBL] [Abstract][Full Text] [Related]
18. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis.
Braithwaite D; Emery J; Walter F; Prevost AT; Sutton S
J Natl Cancer Inst; 2004 Jan; 96(2):122-33. PubMed ID: 14734702
[TBL] [Abstract][Full Text] [Related]
19. Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control.
Kurian AW; Katz SJ
J Clin Oncol; 2020 May; 38(13):1371-1374. PubMed ID: 32097078
[No Abstract] [Full Text] [Related]
20. "I remember how I felt, but I don't remember the gene": Families' experiences of cancer-related genetic testing in childhood.
McGill BC; Wakefield CE; Vetsch J; Lim Q; Warby M; Metcalfe A; Byrne JA; Cohn RJ; Tucker KM
Pediatr Blood Cancer; 2019 Aug; 66(8):e27762. PubMed ID: 31006986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]